Stock research
VLNS The Valens Company Inc.
Healthcare • Drug Manufacturers - Specialty & Generic
The Valens Company Inc. is a Canadian-headquartered enterprise with international reach, focused on the development, manufacturing, and sale of cannabinoid-based products. Its product portfolio encompasses dried...…
The Valens Company Inc. is a Canadian-headquartered enterprise with international reach, focused on the development, manufacturing, and sale of cannabinoid-based products. Its product portfolio encompasses dried cannabis and hemp biomass, alongside a wide array of consumer goods such as tinctures, two-piece caps, soft gels, oral sprays, vape pens, beverages, diverse concentrates, topicals, edibles, and natural health products. Additionally, Valens provides a comprehensive suite of services, including various extraction techniques (CO2, ethanol, hydrocarbon, solvent-less, and terpene), analytical testing, formulation, product development, and custom manufacturing. The company, formerly known as Valens Groworks Corp., officially changed its name to The Valens Company Inc. in June 2020.
3M change
—
Range high
—
Congress · 90d
0
Insiders · 90d
0
Public signal layer
Who is disclosing activity in VLNS?
Price
- Prev Close
- $0.76
- Day High
- $0.77
- Day Low
- $0.75
- 52w High
- $3.00
- 52w Low
- $0.58
- Volume
- 44,625
- Avg Volume
- Beta
- 0
* TTM/most recent where available
Company
- Ticker
- VLNS
- Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- CA
- CEO
- Jeffrey Fallows CFA
- Employees
- 445
- Website
- www.thevalenscompany.com
Key Metrics
- Market Cap
- 61.5M
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price